Record growth for life science tech firm as MES adoption increases globally

A greater regulatory focus on data integrity and customer demand for improved production performance has led to growing use of MES solutions

James O'Brien of Zenith Technologies describes a significant increase in interest in manufacturing execution system services

A global life science technology firm has surpassed the €20m milestone for sales of its manufacturing execution system (MES) services.

Ireland-headquartered Zenith Technologies provides MES and data historian deployment and support services to pharmaceutical and medical device manufacturers globally.

The company has seen sales for this part of the business grow significantly over the last five years, with an average of over 35% year on year growth.

James O’Brien, global MES business unit lead at Zenith Technologies, said: “MES has been the fastest growing segment of our offering and now represents almost a third of our business.”

MES has been the fastest growing segment of our offering and now represents almost a third of our business.

“Factors such as a greater regulatory focus on data integrity and customer demand for improved production performance have led to growing use of MES solutions within the pharmaceutical, biotech and medical device industries, which have traditionally been slow to adopt new technologies.”

“The UK in particular is quickly becoming an MES centre of excellence, with MES sales representing 70% of our business in this market.”

“Similarly, the US and Asia markets offer huge growth potential as the adoption of MES within the life science industry continues to grow across the globe.”

Zenith Technologies now works with nine of the top ten pharmaceutical companies globally and during 2016 its team of engineers grew by almost 40% to over 700 employees.

Companies